Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells $76,501.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 3,385 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $22.60, for a total transaction of $76,501.00. Following the completion of the sale, the chief financial officer directly owned 211,462 shares in the company, valued at $4,779,041.20. This represents a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

David Mountcastle also recently made the following trade(s):

• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total transaction of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $179,690.37.
• On Thursday, April 2nd, David Mountcastle sold 5,566 shares of Privia Health Group stock. The shares were sold at an average price of $20.85, for a total transaction of $116,051.10.
• On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01.
• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total transaction of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The shares were sold at an average price of $21.90, for a total transaction of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total transaction of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total transaction of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total transaction of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Price Performance

PRVA stock opened at $22.95 on Friday. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The firm has a fifty day moving average price of $22.62 and a two-hundred day moving average price of $23.23. The firm has a market cap of $2.89 billion, a price-to-earnings ratio of 143.45, a PEG ratio of 1.71 and a beta of 0.96.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.11. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. The firm had revenue of $603.85 million during the quarter, compared to analyst estimates of $560.99 million. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The firm’s revenue for the quarter was up 25.8% compared to the same quarter last year. As a group, analysts expect that Privia Health Group, Inc. will post 0.35 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Weiss Ratings lowered shares of Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Piper Sandler restated an “overweight” rating and set a $36.00 price target on shares of Privia Health Group in a research report on Thursday, February 26th. Jefferies Financial Group restated a “buy” rating and set a $32.00 price target on shares of Privia Health Group in a research report on Thursday, February 26th. Barclays upped their price target on shares of Privia Health Group from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 25th. Finally, Canaccord Genuity Group lowered their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $31.23.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors have recently modified their holdings of PRVA. Vanguard Group Inc. lifted its holdings in Privia Health Group by 5.3% in the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock worth $301,263,000 after purchasing an additional 607,447 shares during the period. Durable Capital Partners LP lifted its holdings in Privia Health Group by 1.8% in the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after purchasing an additional 203,842 shares during the period. State Street Corp lifted its holdings in Privia Health Group by 1.5% in the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after purchasing an additional 61,853 shares during the period. Van Berkom & Associates Inc. lifted its holdings in Privia Health Group by 5.4% in the first quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after purchasing an additional 208,787 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Privia Health Group by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock worth $66,738,000 after purchasing an additional 31,204 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.